Clinical Trial Update: Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the efficacy and safety of sorafenib in new-onset Type 1 diabetes mellitus; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Type 1 Diabetes | Phase 2 | Status: NOT_YET_RECRUITING